Leading Intrathecal Pumps Type Markets Databank
The Intrathecal Pumps market was valued at $158.2 Million in 2020, and is projected to reach $432.5 Million by 2029 growing at a CAGR of 11.87% from 2021 to 2029. Baclofen segment is expected to be the highest contributor to this market, with $65.3 Million in 2020, and is anticipated to reach $181.1 Million by 2029, registering a CAGR of 12.05%. Baclofen and Bupivacaine segments collectively expected to account for about 67.4% share of the Intrathecal Pumps market in 2020, with the former constituting around 41.3% share. Baclofen and Morphine segments are expected to witness significant growth rates at a CAGR of 12.05% and 12.02% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 49.9% in the overall Intrathecal Pumps market in 2020, and is anticipated to reach 50.6% by 2029.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook